SCOPE 2023: Synopsis of Biospecimen Sample Management Presentation
Hope Meely, chief clinical officer at Slope, provides a brief summary of her SCOPE presentation revolving around biospecimen collection.
In an interview at the 2023 SCOPE conference with ACT Editor-in-Chief, Lisa Henderson, Hope Meely, chief clinical officer at Slope, explains why biospecimens within the precision and personalized medicine spaces have become so valuable. Meely is coming off her conference presentation, "The Hidden Regulatory Risk from Sample Management — What Should You Be Aware of?”
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Related Articles
Operational Strategies That Strengthened the NIMBLE Trial DesignSeptember 16th 2025
How ClinOps Teams Should Evaluate GenAI Tools in Trial DiscoverySeptember 11th 2025
How Research Sites Balance Funding Cuts and Efficiency PressuresAugust 26th 2025
How Flexible Site Models Can Cut Recruitment Costs and TimelinesAugust 21st 2025
Top Questions on Funding Cuts in Clinical ResearchAugust 20th 2025
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
